Ms Joanne Price, MA | |
403 E Rose St, Walla Walla, WA 99362-1218 | |
(509) 525-2759 | |
(509) 525-1998 |
Full Name | Ms Joanne Price |
---|---|
Gender | Female |
Speciality | Audiologist-hearing Aid Fitter |
Location | 403 E Rose St, Walla Walla, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588734206 | NPI | - | NPPES |
7055809 | Medicaid | WA | |
8390460 | Medicaid | WA | |
9092008 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | LD00001730 (Washington) | Secondary |
237600000X | Audiologist-hearing Aid Fitter | LD00001730 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Joanne Price, MA 403 E Rose St, Walla Walla, WA 99362-1218 Ph: (509) 525-2759 | Ms Joanne Price, MA 403 E Rose St, Walla Walla, WA 99362-1218 Ph: (509) 525-2759 |
News Archive
Sanford-Burnham scientists have identified the B and T Lymphocyte Attenuator (BTLA) inhibitory receptor as a key factor in limiting inflammatory responses, particularly in the skin. The study, published online today in Immunity, provides clarity on how T cells get fired up to protect against pathogens, and then cool down to restore immune homeostasis.
Older women who experience at least one full-blown panic attack may have an increased risk of having a heart attack or stroke and an increased risk of death in the next five years, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Research from the University of Copenhagen is shedding new light on the brain's complicated barrier tissue. The blood-brain barrier is an effective barrier which protects the brain, but which at the same time makes it difficult to treat diseases such as Alzheimer's.
New clinical data from a study of 570 men published in the peer-reviewed Journal of Urology support the use of PROGENSA PCA3 as a tool for diagnosing prostate cancer. The study confirms that PROGENSA PCA3, the world's first gene-based urine test to help detect prostate cancer, can provide clinicians with valuable information that helps guide diagnosis.
› Verified 1 days ago